Depth of Response Correlates with Improved Outcomes for Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone
Consent Codes
HMBFocus / Diseases
Multiple MyelomaStudy Design
Case SetData Types
OTHER, RNA-Seq, Custom targeted DNA/RNA sequencing, RNA Seq (NGS)Subjects
20